Literature DB >> 6250795

Somatogenic receptors of rat liver: regulation by insulin.

R C Baxter, J M Bryson, J R Turtle.   

Abstract

Somatogenic (i.e. GH) receptors have been studied on liver microsomal membranes from male and female rats. Tracer bovine GH was displaced from its binding sites by GHs of various species, but was displaced only weakly by PRLs. Specific bovine GH binding was 3.5-fold higher to female rat liver membranes than to membranes from males. Streptozotocin-induced diabetes significantly reduced binding, by 80% in females and 50% in males, while insulin therapy to normalize weight gain reversed the decrease in binding. Competitive binding curves were consistent with two independent classes of binding site: low affinity sites with K equal to 0.5 nm-1 in both sexes, and high affinity sites with K equal to 12.1 nm-1 in males and 21.4 nm-1 in females (P less than 0.001). The addition of excess ovine PRL caused a substantial loss of high affinity binding with little loss in the low affinity region, suggesting a weak somatogenic role for ovine PRL. In diabetic animals, low affinity sites were unchanged from normal, while high affinity sites were decreased in number, with no change in affinity, and restored on insulin therapy. Serum immunoreactive rat GH levels were the same in normal and diabetic, male and female animals. These studies suggest that the apparent hepatic resistance to GH seen in diabetes when liver somatomedin release is low despite normal serum GH might be explained by the loss of GH receptors in this condition.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6250795     DOI: 10.1210/endo-107-4-1176

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  44 in total

1.  Insulin and insulin-like growth factor-I acutely inhibit surface translocation of growth hormone receptors in osteoblasts: a novel mechanism of growth hormone receptor regulation.

Authors:  K C Leung; M J Waters; I Markus; W R Baumbach; K K Ho
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

2.  Effects of growth hormone and free fatty acids on insulin sensitivity in patients with type 1 diabetes.

Authors:  Burak Salgin; Maria L Marcovecchio; Rachel M Williams; Sarah J Jackson; Leslie J Bluck; Sandy M Humphreys; Carlo L Acerini; David B Dunger
Journal:  J Clin Endocrinol Metab       Date:  2009-06-30       Impact factor: 5.958

3.  Role of certain hormones with general metabolic action in the expression of sexual differentiation of the rat liver with respect to a special estrogen-binding protein.

Authors:  O V Smirnova; T G Vishnyakova; V B Rozen
Journal:  Neurosci Behav Physiol       Date:  1990 Jan-Feb

4.  Plasma clearance of heterogeneous growth hormone components in the rat: effects of diabetes and starvation.

Authors:  T Jolin; C González
Journal:  J Endocrinol Invest       Date:  1990-03       Impact factor: 4.256

5.  One-hour postload plasma glucose levels are associated with kidney dysfunction.

Authors:  Elena Succurro; Franco Arturi; Marina Lugarà; Alessandro Grembiale; Teresa Vanessa Fiorentino; Vittoria Caruso; Francesco Andreozzi; Angela Sciacqua; Marta Letizia Hribal; Francesco Perticone; Giorgio Sesti
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 8.237

Review 6.  Insulin-Like growth factor I: implications in aging.

Authors:  E Arvat; F Broglio; E Ghigo
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

7.  IL-17 and insulin/IGF1 enhance adhesion of prostate cancer cells to vascular endothelial cells through CD44-VCAM-1 interaction.

Authors:  Chong Chen; Qiuyang Zhang; Sen Liu; Keshab R Parajuli; Yine Qu; Jiandong Mei; Zhiquan Chen; Hui Zhang; Damir B Khismatullin; Zongbing You
Journal:  Prostate       Date:  2015-02-14       Impact factor: 4.104

8.  LEPROT and LEPROTL1 cooperatively decrease hepatic growth hormone action in mice.

Authors:  Thierry Touvier; Françoise Conte-Auriol; Olivier Briand; Céline Cudejko; Réjane Paumelle; Sandrine Caron; Eric Baugé; Yves Rouillé; Jean-Pierre Salles; Bart Staels; Bernard Bailleul
Journal:  J Clin Invest       Date:  2009-11-09       Impact factor: 14.808

9.  The effect of acute and chronic insulin administration on insulin-like growth factor-I expression in the pituitary-intact and hypophysectomised rat.

Authors:  E A Salamon; J Luo; L J Murphy
Journal:  Diabetologia       Date:  1989-06       Impact factor: 10.122

10.  Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with type 1 (insulin-dependent) diabetes mellitus.

Authors:  G Massa; L Dooms; R Bouillon; M Vanderschueren-Lodeweyckx
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.